Journal article
Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review
Abstract
BACKGROUND: To systematically review neoadjuvant and adjuvant therapy options for women with newly diagnosed stage II-IV ovarian cancer.
METHODS: Phase III trials were searched using MEDLINE, EMBASE, and Cochrane Library. Maintenance therapies were excluded.
Authors
Hirte H; Poon R; Yao X; May T; Ethier J-L; Petz L; Speakman J; Elit L
Journal
Critical Reviews in Oncology/Hematology, Vol. 162, ,
Publisher
Elsevier
Publication Date
June 2021
DOI
10.1016/j.critrevonc.2021.103324
ISSN
1040-8428